Skip to main content

Table 2 Elevated (↑) or decreased (↓) risk of restenosis, target laesion vascularization (TLR), death or myocardial infarction (MI) of the different groups of glucose lowering agents after PCI.

From: The role of glucose lowering agents on restenosis after percutaneous coronary intervention in patients with diabetes mellitus

Risk Modulation of Glucose Lowering Agents in Diabetics After PCI
Agent Restenosis TLR Death MI
TZDs -
Sulfonylurea - -
Biguanides - -
Insulin